Investment In Reproductive Health R&D In Developing Countries Is Small
Global Health Technology Coalition’s “Breakthroughs”: The state of reproductive health R&D for developing countries
“…Dale Halliday — an analyst at Policy Cures — discusses the finding of Policy Cures’ report on funding for reproductive health technology research and development (R&D) in developing countries” and notes that “[c]onsidering the health burden, capacity for health improvements, and potential impact on broader poverty indicators, as well as the size of the reproductive health R&D sector as a whole, investment in R&D for reproductive health products in developing countries is small” (2/4).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.